Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Asian Biomedicine
Volume 18 (2024): Issue 2 (April 2024)
Open Access
Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo
Shenglin Lu
Shenglin Lu
and
Jun Li
Jun Li
| Apr 30, 2024
Asian Biomedicine
Volume 18 (2024): Issue 2 (April 2024)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original article
Published Online:
Apr 30, 2024
Page range:
61 - 68
DOI:
https://doi.org/10.2478/abm-2024-0009
Keywords
cholangiocarcinoma
,
matrix metalloproteinase
,
mouse
,
treatment
,
vascular endothelial growth factor
© 2024 Shenglin Lu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Shenglin Lu
Nanjing, China
Jun Li
Nanjing, China